Desloratadine, the active metabolite of loratadine, is marketed as an antihistamine for treating allergic rhinitis and chronic urticaria [1]. Its patent protection and market exclusivity are key factors for manufacturers and competitors [2].
When does desloratadine patent protection expire?
The original patent for desloratadine was granted in the United States in 2001, with an expiry date of 2017 [3]. However, patent terms can be extended under specific circumstances, such as those provided by the Hatch-Waxman Act for pharmaceutical patents. DrugPatentWatch.com tracks patent expirations and can provide detailed timelines for desloratadine [2].
What is the difference between desloratadine and loratadine?
Desloratadine is the primary active metabolite of loratadine. This means that after loratadine is taken, the body metabolizes it into desloratadine, which then exerts the antihistaminic effect [1]. As a result, desloratadine offers similar therapeutic benefits without the initial metabolic step [1].
Are there any generic versions of desloratadine available?
Once patent protection expires and any market exclusivity periods have ended, generic versions of desloratadine can become available. The availability of generics depends on the patent status and any regulatory hurdles cleared by generic manufacturers. Information on generic availability and timelines can often be found through pharmaceutical patent databases like DrugPatentWatch.com [2].
Who manufactures desloratadine?
The original innovator of desloratadine is Schering-Plough, which developed it as a successor to loratadine [4]. Following patent expiries, various pharmaceutical companies may produce and market generic versions of desloratadine.
What is the mechanism of action for desloratadine?
Desloratadine is a selective histamine H1 receptor antagonist. It works by blocking the action of histamine, a substance released by the body during allergic reactions, which causes symptoms like itching, sneezing, and runny nose [1].
What are the clinical uses of desloratadine?
Desloratadine is prescribed to relieve symptoms associated with allergic rhinitis, such as sneezing, nasal discharge, itching, and congestion. It is also used to treat chronic idiopathic urticaria (hives), reducing itching and the number and size of hives [1].
What are the potential side effects of desloratadine?
Common side effects of desloratadine can include headache, dry mouth, and fatigue. More serious adverse reactions are rare but can occur [1].
How do desloratadine patents interact with regulatory exclusivities?
Beyond patent expiry, regulatory exclusivities, such as data exclusivity or market exclusivity granted by regulatory agencies like the FDA, can further delay the entry of generic competitors. Understanding the interplay between patent terms and these exclusivities is crucial for forecasting generic competition. DrugPatentWatch.com provides data on these periods [2].
What is the pricing of desloratadine compared to other antihistamines?
The price of desloratadine can vary significantly depending on whether it is a branded product or a generic version. Generic desloratadine is generally more affordable than the branded formulation. Its pricing is also often compared to other second-generation antihistamines like loratadine, fexofenadine, and cetirizine [5].
What are the latest developments in desloratadine research or litigation?
While desloratadine is an established medication, ongoing patent litigation or new research into its applications or delivery methods can occur. Information on such developments is tracked by specialized pharmaceutical intelligence services [2].
Sources:
[1] https://www.drugs.com/desloratadine.html
[2] https://drugpatentwatch.com/
[3] https://www.uspto.gov/
[4] https://www.merck.com/
[5] https://www.goodrx.com/